Brokerages Set Relx Plc (OTCMKTS:RLXXF) Price Target at $28.80

Shares of Relx Plc (OTCMKTS:RLXXF) have earned a consensus rating of “Buy” from the eight analysts that are currently covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $28.80.

RLXXF has been the topic of several recent research reports. Morgan Stanley reissued a “buy” rating on shares of Relx in a research note on Thursday, July 1st. UBS Group reissued a “hold” rating on shares of Relx in a research note on Tuesday, June 29th. JPMorgan Chase & Co. reissued a “buy” rating on shares of Relx in a research note on Tuesday, August 17th. Finally, Credit Suisse Group set a $28.80 target price on Relx and gave the company a “buy” rating in a research report on Sunday, July 18th.

Shares of RLXXF traded up $0.20 during midday trading on Friday, hitting $30.60. The stock had a trading volume of 1,267 shares, compared to its average volume of 13,139. The company has a 50 day simple moving average of $29.81 and a two-hundred day simple moving average of $27.40. Relx has a twelve month low of $19.53 and a twelve month high of $30.75.

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.

See Also: Understanding the different types of bonds

Analyst Recommendations for Relx (OTCMKTS:RLXXF)

Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.